Santo “Sandy” Costa, is currently Of Counsel at the law firm William Mullen Maupin Taylor, P.A. Mr. Costa previously held several positions with Quintiles Transnational Corp., including President and Chief Operating Officer and Vice-Chairman. Prior to joining Quintiles, Mr. Costa spent 23 years in the pharmaceutical industry, most recently as Senior Vice President, Administration and General Counsel of Glaxo Inc. where he also sat on the company's board of directors. In addition, Mr. Costa sits on the board of directors of NPS Pharmaceuticals, CV Therapeutics Inc., DigiScripts, LaboPharm, Constella Group and is Chairman of NeuroMedix. Mr. Costa is an adjunct professor in the clinical research program at the Campbell University School of Pharmacy. He also sits on the Board of the Duke Cancer Patient Support Program and the Duke University Medical Center Board of Visitors. Mr. Costa received his B.S. in pharmacy and his J.D. from St. John's University.